Cohance Lifesciences Limited
COHANCE
Hisse Senetlerindeki Sıralama
#6370
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Hisse Fiyatı
$5.05
Son senkronizasyon: 2026-10-19
Piyasa Değeri
$1.93B
Değişim (1 gün)
-1.44%
Değişim (1 yıl)
-57.38%
Ülke
IN
Ticaret Cohance Lifesciences Limited (COHANCE)
Kategori
Healthcare
Cohance Lifesciences Limited (COHANCE) için EPS
June 2025 itibariyle EPS TTM: $0.11
Cohance Lifesciences Limited şirketinin en son finansal raporlarına ve hisse senedi fiyatına göre, şirketin mevcut EPS'si (TTM) $0.11'dir. 2024 yılı sonunda, şirketin EPS'si $0.14 idi; bu, 2023 yılındaki EPS olan $0.20 ile önceki yıla göre azalma.
Cohance Lifesciences Limited için 2019 - 2026 arasındaki EPS geçmişi
Her yıl sonunda EPS
| Yıl | EPS | Değiştir |
|---|---|---|
| 2026 (TTM) | $0.11 | -9.42% |
| 2025 | $0.12 | -13.07% |
| 2024 | $0.14 | -28.03% |
| 2023 | $0.20 | -16.30% |
| 2022 | $0.23 | 20.83% |
| 2021 | $0.19 | 17.60% |
| 2020 | $0.17 | 167.48% |
| 2019 | $0.06 | 0.00% |
Benzer şirketler veya rakipler için EPS
| Şirket | EPS | EPS Farkı | Ülke |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 411.78% |
IN
|
